A detailed history of Mml Investors Services, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mml Investors Services, LLC holds 190,689 shares of GILD stock, worth $17.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
190,689
Previous 168,498 13.17%
Holding current value
$17.9 Million
Previous $11.6 Million 38.28%
% of portfolio
0.06%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$66.59 - $83.99 $1.48 Million - $1.86 Million
22,191 Added 13.17%
190,689 $16 Million
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $611,165 - $705,332
-9,678 Reduced 5.43%
168,498 $11.6 Million
Q1 2024

May 14, 2024

SELL
$71.58 - $87.29 $1.35 Million - $1.64 Million
-18,834 Reduced 9.56%
178,176 $13.1 Million
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $1.09 Million - $1.23 Million
14,854 Added 8.15%
197,010 $16 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $411,032 - $448,444
-5,559 Reduced 2.96%
182,156 $13.7 Million
Q2 2023

Aug 14, 2023

SELL
$76.01 - $86.7 $84,751 - $96,670
-1,115 Reduced 0.59%
187,715 $14.5 Million
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $3.18 Million - $3.63 Million
-41,158 Reduced 17.9%
188,830 $15.7 Million
Q4 2022

Feb 13, 2023

BUY
$62.32 - $89.47 $1.02 Million - $1.46 Million
16,340 Added 7.65%
229,988 $19.7 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $643,329 - $734,848
10,805 Added 5.33%
213,648 $13.2 Million
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $1.4 Million - $1.57 Million
24,213 Added 13.55%
202,843 $12.5 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $845,574 - $1.06 Million
14,599 Added 8.9%
178,630 $10.6 Million
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $191,460 - $217,311
2,951 Added 1.83%
164,031 $11.9 Million
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $1.22 Million - $1.32 Million
18,080 Added 12.64%
161,080 $11.3 Million
Q2 2021

Aug 13, 2021

BUY
$63.47 - $69.35 $182,793 - $199,727
2,880 Added 2.06%
143,000 $9.85 Million
Q1 2021

May 14, 2021

BUY
$60.0 - $68.46 $684,900 - $781,470
11,415 Added 8.87%
140,120 $9.06 Million
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $254,925 - $290,475
-4,500 Reduced 3.38%
128,705 $7.5 Million
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $2.05 Million - $2.58 Million
33,089 Added 33.05%
133,205 $8.42 Million
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $1.3 Million - $1.51 Million
-17,969 Reduced 15.22%
100,116 $7.7 Million
Q1 2020

May 14, 2020

BUY
$62.63 - $80.22 $1.28 Million - $1.64 Million
20,491 Added 21.0%
118,085 $8.83 Million
Q4 2019

Feb 11, 2020

BUY
$61.62 - $67.78 $307,422 - $338,154
4,989 Added 5.39%
97,594 $6.34 Million
Q3 2019

Nov 14, 2019

BUY
$62.51 - $69.0 $1.93 Million - $2.13 Million
30,862 Added 49.98%
92,605 $5.87 Million
Q2 2019

Aug 13, 2019

BUY
$61.87 - $69.38 $119,718 - $134,250
1,935 Added 3.24%
61,743 $4.17 Million
Q1 2019

May 10, 2019

BUY
$62.53 - $70.05 $442,774 - $496,024
7,081 Added 13.43%
59,808 $3.89 Million
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $295,435 - $385,520
-4,880 Reduced 8.47%
52,727 $3.3 Million
Q3 2018

Nov 07, 2018

BUY
$71.28 - $78.92 $944,032 - $1.05 Million
13,244 Added 29.85%
57,607 $4.45 Million
Q2 2018

Aug 13, 2018

BUY
$64.88 - $75.68 $94,335 - $110,038
1,454 Added 3.39%
44,363 $3.14 Million
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $501,649 - $611,565
-6,887 Reduced 13.83%
42,909 $3.24 Million
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $246,463 - $289,313
3,464 Added 7.48%
49,796 $3.57 Million
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $3.34 Million - $3.96 Million
46,332
46,332 $3.75 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.